Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The Fund performed roughly in line with the Benchmark, during a challenging ...

Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...

However in the US, where its maker Eli Lilly is headquartered ... Alongside Ozempic and Wegov – the anti-diabetes and weight-loss jabs made by Danish company Novo Nordisk – Mounjaro and ...

The Diabetes Support Group meets from 11 a.m.-noon, the fourth Monday of the month in the Lilly Lake Conference Room, at Northwest Health — LaPorte, 1331 State St. Registration is not required.

Now, in a rational world, insurers would immediately switch to the generic drug so patients with diabetes could save money. Instead, pharmacy benefit managers — which determine what drugs ...

Ozempic is approved for the management of type 2 diabetes, but it’s also used off ... Once you sign up, you can book an appointment with a board certified healthcare professional who will ...

Companies including Biogen and Eli Lilly & Co. have spent billions of ... Novo Nordisk is testing whether the ingredient — which is in its diabetes and weight-loss drugs — can benefit patients ...